Conflicts of Interest and the Future of Medicine: The United States, France, and Japan
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
As the promise of health care reform in the United States continues to face political and legal hurdles, few questions evoke as heated a debate as those surrounding cost control. Though most stakeholders agree that too many dollars change hands in the U.S. health care economy, politically tenable solutions to the problem have been elusive, as evidenced by the paucity of substantive cost-control measures in the current reform efforts. At the heart of the debate are fundamental tensions between patient choice and societal cost, between autonomous physician decision-making and adherence to clinical guidelines, and between free health-care markets and government oversight of those markets.
This past spring, the Independent Payment Advisory Board (IPAB) was introduced in the United States as a key component of the deficit reduction plan and was designed as a neutral body with the authority to cut Medicare spending if the federal health insurance program exceeded certain targets. A predictabl ...
- Association of American Medical Colleges (AAMC) Task Force on Financial Conflicts of Interest in Clinical Research. 2001. Protecting subjects, preserving trust, promoting progress: Policy and guidelines for the oversight of individual financial interests in human subjects research. Washington, DC.
- Department of Health and Human Services. 2004. Financial relationships and interests in research involving human subjects: Guidance for human subject protection. Federal Register 68: 15456–15460.
- Grande, D., D.L. Frosch, A.W. Perkins, and B.E. Kahn. 2009. Effect of exposure to small pharmaceutical promotional items on treatment preferences. Archives of Internal Medicine 169(9): 887–93. CrossRef
- Krugman, P. 2011. Patients are not consumers. The New York Times, April 21, A23.
- Licurse, A., E. Barber, S. Joffe, and C. Gross. 2010. The impact of disclosing financial ties in research and clinical care: A systematic review. Archives Internal Medicine 170(8): 675–682. CrossRef
- Mccarthy, K. 2010. Consumers wary of doctors who take drug-company dollars. http://news.consumerreports.org/health/2010/10/propublica-drug-company-payments-to-doctors-disturb-most-of-us-our-poll-finds.html. Accessed 5 February 2011.
- Pear, R. 2011. Obama panel to curb medicare finds foes in both parties. The New York Times, April 20, A3.
- Patient Protection and Affordable Care Act (H.R.3590). http://democrats.senate.gov/pdfs/reform/patent-protectition-affordable-care-act-as-passed.pdf. Accessed 1 September 2011.
- Sirovich, B., P.M. Gallagher, D.E. Wennberg, and E.S. Fisher. 2008. Discretionary decision making by primary care physicians and the cost of U.S. health care. Health Affairs 27(3): 813–823. CrossRef
- Song, Y., J. Skinner, J. Bynum, J. Sutherland, J. Wennberg, and E.S. Fisher. 2010. Regional variations in diagnostic practices. New England Journal of Medicine 363(1): 45–53. CrossRef
- Wazana, A. 2000. Physicians and the pharmaceutical industry: Is a gift ever just a gift? JAMA 283(3): 373–380. CrossRef
- Zhang, Y., K. Baicker, and J.P. Newhouse. 2010a. Geographic variation in the quality of prescribing. New England Journal of Medicine 363(21): 1985–1988. CrossRef
- Zhang, Y., K. Baicker, and J.P. Newhouse. 2010b. Geographic variation in Medicare drug spending. New England Journal of Medicine 363(5): 405–409. CrossRef
- Conflicts of Interest and the Future of Medicine: The United States, France, and Japan
Journal of Bioethical Inquiry
Volume 8, Issue 4 , pp 383-386
- Cover Date
- Print ISSN
- Online ISSN
- Springer Netherlands
- Additional Links
- Author Affiliations
- 1. Division of Internal Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA
- 2. Harvard Medical School, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, 1620 Tremont St. Suite 3030, Boston, MA, USA